BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25640145)

  • 1. Assessment of a scoring system for Basal Cell Carcinoma with multi-beam optical coherence tomography.
    Wahrlich C; Alawi SA; Batz S; Fluhr JW; Lademann J; Ulrich M
    J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1562-9. PubMed ID: 25640145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical coherence tomography of basal cell carcinoma: density and signal attenuation.
    Yücel D; Themstrup L; Manfredi M; Jemec GB
    Skin Res Technol; 2016 Nov; 22(4):497-504. PubMed ID: 27264340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of optical coherence tomography in actinic keratosis and basal cell carcinoma.
    Olsen J; Themstrup L; De Carvalho N; Mogensen M; Pellacani G; Jemec GB
    Photodiagnosis Photodyn Ther; 2016 Dec; 16():44-49. PubMed ID: 27519350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo high-definition optical coherence tomography of basal cell carcinoma compared to frozen-section histology in micrographic surgery: a pilot study.
    Maier T; Kulichová D; Ruzicka T; Kunte C; Berking C
    J Eur Acad Dermatol Venereol; 2014 Jan; 28(1):80-5. PubMed ID: 23279136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphology of basal cell carcinoma in high definition optical coherence tomography: en-face and slice imaging mode, and comparison with histology.
    Maier T; Braun-Falco M; Hinz T; Schmid-Wendtner MH; Ruzicka T; Berking C
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e97-104. PubMed ID: 22540280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo differentiation of common basal cell carcinoma subtypes by microvascular and structural imaging using dynamic optical coherence tomography.
    Themstrup L; De Carvalho N; Nielsen SM; Olsen J; Ciardo S; Schuh S; Nørnberg BM; Welzel J; Ulrich M; Pellacani G; Jemec GBE
    Exp Dermatol; 2018 Feb; 27(2):156-165. PubMed ID: 29215761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-definition optical coherence tomography algorithm for discrimination of basal cell carcinoma from clinical BCC imitators and differentiation between common subtypes.
    Boone MA; Suppa M; Pellacani G; Marneffe A; Miyamoto M; Alarcon I; Ruini C; Hofmann-Wellenhof R; Malvehy J; Jemec GB; Del Marmol V
    J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1771-80. PubMed ID: 25712021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a Combined Reflectance Confocal Microscopy-Optical Coherence Tomography Device for Detection and Depth Assessment of Basal Cell Carcinoma.
    Sahu A; Yélamos O; Iftimia N; Cordova M; Alessi-Fox C; Gill M; Maguluri G; Dusza SW; Navarrete-Dechent C; González S; Rossi AM; Marghoob AA; Rajadhyaksha M; Chen CJ
    JAMA Dermatol; 2018 Oct; 154(10):1175-1183. PubMed ID: 30140851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid ex vivo examination of Mohs specimens using optical coherence tomography.
    Rashed D; Shah D; Freeman A; Cook RJ; Hopper C; Perrett CM
    Photodiagnosis Photodyn Ther; 2017 Sep; 19():243-248. PubMed ID: 28619614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphologic features of basal cell carcinoma using the en-face mode in frequency domain optical coherence tomography.
    von Braunmühl T; Hartmann D; Tietze JK; Cekovic D; Kunte C; Ruzicka T; Berking C; Sattler EC
    J Eur Acad Dermatol Venereol; 2016 Nov; 30(11):1919-1925. PubMed ID: 27581090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological correlates of basal cell carcinoma in the slice and en face imaging modes of high-definition optical coherence tomography.
    Gambichler T; Plura I; Kampilafkos P; Valavanis K; Sand M; Bechara FG; Stücker M
    Br J Dermatol; 2014 Jun; 170(6):1358-61. PubMed ID: 24359160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Line-field optical coherence tomography: in vivo diagnosis of basal cell carcinoma subtypes compared with histopathology.
    Ruini C; Schuh S; Gust C; Kendziora B; Frommherz L; French LE; Hartmann D; Welzel J; Sattler E
    Clin Exp Dermatol; 2021 Dec; 46(8):1471-1481. PubMed ID: 34047380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sensitivity and specificity of optical coherence tomography for the assisted diagnosis of nonpigmented basal cell carcinoma: an observational study.
    Ulrich M; von Braunmuehl T; Kurzen H; Dirschka T; Kellner C; Sattler E; Berking C; Welzel J; Reinhold U
    Br J Dermatol; 2015 Aug; 173(2):428-35. PubMed ID: 25904111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical coherence tomography for presurgical margin assessment of non-melanoma skin cancer - a practical approach.
    Alawi SA; Kuck M; Wahrlich C; Batz S; McKenzie G; Fluhr JW; Lademann J; Ulrich M
    Exp Dermatol; 2013 Aug; 22(8):547-51. PubMed ID: 23879814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of Basal Cell Carcinoma Subtypes in Multi-Beam Swept Source Optical Coherence Tomography (MSS-OCT).
    Meekings A; Utz S; Ulrich M; Bienenfeld A; Nandanan N; Fisher J; McKenzie G; Siegel DM; Feldman E; Markowitz O
    J Drugs Dermatol; 2016 May; 15(5):545-50. PubMed ID: 27168263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical coherence tomography in the diagnosis of basal cell carcinoma.
    Hussain AA; Themstrup L; Jemec GB
    Arch Dermatol Res; 2015 Jan; 307(1):1-10. PubMed ID: 25223745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Pitfalls for differentiating basal cell carcinoma from non-basal cell carcinoma on optical coherence tomography: A clinical series'.
    Wolswijk T; Nelemans PJ; Adan F; Abdul Hamid M; Mosterd K
    J Dermatol; 2024 Jan; 51(1):40-47. PubMed ID: 37927296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo optical coherence tomography of basal cell carcinoma.
    Gambichler T; Orlikov A; Vasa R; Moussa G; Hoffmann K; Stücker M; Altmeyer P; Bechara FG
    J Dermatol Sci; 2007 Mar; 45(3):167-73. PubMed ID: 17215110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optical coherence tomography imaging of non-melanoma skin cancer undergoing imiquimod therapy.
    Banzhaf CA; Themstrup L; Ring HC; Mogensen M; Jemec GB
    Skin Res Technol; 2014 May; 20(2):170-6. PubMed ID: 24103017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of optical coherence tomography imaging in the diagnosis of non-melanoma skin cancer and benign lesions versus normal skin: observer-blinded evaluation by dermatologists and pathologists.
    Mogensen M; Joergensen TM; Nürnberg BM; Morsy HA; Thomsen JB; Thrane L; Jemec GB
    Dermatol Surg; 2009 Jun; 35(6):965-72. PubMed ID: 19397661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.